The International Organization for Standardization (ISO) recently issued crucial guidance for the transportation of cells for therapeutic use (ISO 21973). It is imperative for transportation service providers and therapy manufacturers to comply with these standards in order to ensure cell quality, safety and efficacy during the transportation process.
This white paper discusses key recommendations and changes that interested parties should review and evaluate when planning their clinical and commercial distribution strategies for cell and gene therapies.
